diabetes Archives - Mediarabe

Could Type 1 Diabetes Begin in Utero?

October 13, 2020

Infants might develop type 1 diabetes in the first 6 months of life and seems to be unrelated to known genetic risk factors; rather, it appears linked to low birth weight, say UK researchers.

They believe the discovery could mean the disease starts in utero.

Others are skeptical, however.

The team studied 166 infants with diabetes diagnosed before 6 months of age and compared them to babies with the more common neonatal diabetes and children diagnosed with type 1 diabetes at older ages.

The combination of high type 1 diabetes genetic risk score (T1D-GRS), presence of islet-specific autoantibodies, and evidence of a rapid loss of insulin secretion all suggest that the infants had type 1 diabetes.

And notably, they all had a lower median birth weight than international reference standards.

“This study proves that type 1 diabetes can present in the first few months of life, and in a tiny

Scripps Whittier Diabetes Institute Granted $3.3 Million for Mental Health

October 12, 2020

| No Comments

| Better Health

Share This Article:

The Scripps Whittier Diabetes Institute was awarded a five-year, $3.3 million grant Monday to study the integration of mental health services in the care of patients with type 1 diabetes.

Support Times of San Diego’s growth
with a small monthly contribution

In 2016, the American Diabetes Association released guidelines for screening and treating patients with diabetes distress — the name given to the often hidden emotional burden that many people experience when managing a demanding chronic disease like diabetes.

Researchers at Scripps Whittier will use the funds from the National Institute of Diabetes and Digestive and Kidney Diseases to launch a large- scale, randomized, controlled clinical trial that will evaluate whether the integration of

Scripps Whittier Diabetes Institute Given $3.3M For Mental Health

October 12, 2020

| No Comments

| Better Health

SAN DIEGO, CA — The Scripps Whittier Diabetes Institute was awarded a five-year, $3.3 million grant Monday to study the integration of mental health services in the care of patients with type 1 diabetes.

In 2016, the American Diabetes Association released guidelines for screening and treating patients with diabetes distress — the name given to the often hidden emotional burden that many people experience when managing a demanding chronic disease like diabetes.

Researchers at Scripps Whittier will use the funds from the National Institute of Diabetes and Digestive and Kidney Diseases to launch a large-scale, randomized, controlled clinical trial that will evaluate whether the integration of diabetes distress care with routine medical care results in better management of diabetes and better health-related quality of life.

“Diabetes distress is not a psychological disorder, but rather represents the understandable emotional strain of living with a life-long condition,” said Addie Fortmann, a clinical

Mice with diabetes successfully treated with EMFs

October 12, 2020

| No Comments

| Health

Researchers have worked out how to use electromagnetic fields to treat mice with type 2 diabetes.

Scientists have discovered that they can successfully treat type 2 diabetes in mouse models by exposing the rodents to electromagnetic fields.

The research, which appears in the journal Cell Metabolism, opens the door to further studies confirming the findings and exploring whether the therapy could be suitable for use in humans.

According to the Centers for Disease Control and Prevention (CDC), more than 34 million people — approximately 1 in 10 — in the United States have diabetes. Of these individuals, the vast majority have type 2 diabetes.

Type 2 diabetes occurs when a person’s cells do not react to the hormone insulin properly. Insulin, which the pancreas produces, mediates the ability of a person’s cells to receive blood sugar.

In this situation, a person’s body can tell that their cells are not

Treatment Reverses Young Man’s Type 1 Diabetes. Will It Last? | Health News

October 8, 2020

| No Comments

| Health News

By Serena Gordon
HealthDay Reporter

(HealthDay)

WEDNESDAY, Oct. 7, 2020 (HealthDay News) — After starting a drug that’s officially approved to treat a type of blood cancer, a young man with type 1 diabetes was able to stop using insulin.

He’s been off insulin since August 2018 — more than two years.

Dr. Lisa Forbes — his doctor and co-author of a letter describing his case in the Oct. 8 issue of the New England Journal of Medicine — stopped short of calling the drug a cure for type 1 diabetes.

But Forbes, an assistant professor of pediatrics, immunology, allergy and rheumatology at Baylor College of Medicine in Houston, said the patient’s diabetes appears to have been reversed. She hopes it will stay that way as long as he keeps taking the oral medication called ruxolitinib (Jakafi). It’s in a class of medications known as JAK inhibitors.

Whether this drug

Diabetes Outreach teams up to offer ‘Better Choices, Better Health’ interactive program | News, Sports, Jobs

October 6, 2020

| No Comments

| Better Health

Improving blood sugar in Type 2 diabetes improves cognitive scores, study says

October 5, 2020

| No Comments

| Health News

Oct. 5 (UPI) — Controlling blood sugar levels helped people with Type 2 diabetes who were overweight improve cognitive scores, but losing weight, exercise had mixed results, a new study shows.

More than a quarter of U.S. adults 65 or older have Type 2 diabetes, which doubles the risk of cognitive impairment and dementia, including Alzheimer’s disease, according to a statement from the Pennington Biomedical Research Center.

“It’s important to properly control your blood sugar to avoid the bad brain effects of your diabetes,” said study author Owen Carmichael said in a statement.

“Don’t think you can simply let yourself get all the way to the obese range, lose some of the weight, and everything in the brain is fine,” said Carmichael, a professor and director of Biomedical Imaging at Pennington Biomedical Research Center. “The brain might have already turned a corner that it can’t turn back from.”

The study,

Lohmans’ $4 million donation to fund diabetes center at Daytona’s Halifax Medical Center

October 3, 2020

| No Comments

| Health Center

ORMOND BEACH — When Lowell Lohman met a few years ago with medical researchers working to find a cure for diabetes, he offered praise for their dedication, but also a suggestion:

a person cutting a cake: Nancy Lohman (right) and Halifax Health CEO Jeff Feasel (left) watch as Lowell Lohman signs paperwork to make official the couple's $4 million donation to fund a new Lohman Diabetes Center of Excellence at Halifax Health Medical Center in Daytona Beach.

© Nigel Cook/News-Journal
Nancy Lohman (right) and Halifax Health CEO Jeff Feasel (left) watch as Lowell Lohman signs paperwork to make official the couple’s $4 million donation to fund a new Lohman Diabetes Center of Excellence at Halifax Health Medical Center in Daytona Beach.

“I told them, ‘While you’re searching for it, please make the day-to-day struggle of being a diabetic easier,’” said Lohman, a successful entrepreneur who has been a Type 1 diabetic for 55 years.

Now, Lohman and his wife, Nancy, are making a $4 million donation to support that goal by establishing Lohman Diabetes Center of Excellence at Halifax Health Medical Center in Daytona Beach. It is conceived as a one-stop resource center for diabetes patients

Lohmans’ $4 million donation funds diabetes center at Halifax Health

October 3, 2020

| No Comments

| Health Center

Jim Abbott

| The Daytona Beach News-Journal

ORMOND BEACH — When Lowell Lohman met a few years ago with medical researchers working to find a cure for diabetes, he offered praise for their dedication, but also a suggestion:

“I told them, ‘While you’re searching for it, please make the day-to-day struggle of being a diabetic easier,’” said Lohman, a successful entrepreneur who has been a Type 1 diabetic for 55 years.

Now, Lohman and his wife, Nancy, are making a $4 million donation to support that goal by establishing Lohman Diabetes Center of Excellence at Halifax Health Medical Center in Daytona Beach. It is conceived as a one-stop resource center for diabetes patients seeking access to world-class endocrinologists, on-site lab work, educational and lifestyle coaching, the Lohmans said.

“That’s our hope, that it’s a navigation center, a collaborative team approach to diabetes care,” said Nancy Lohman, who joined her husband

Call to Action for Screening, Early Treatment of Diabetes

October 3, 2020

| No Comments

| Health

People with type 2 diabetes derive benefit from earlier detection and treatment, suggests a decade-long follow-up of the Anglo-Danish-Dutch Study in General Practice of Intensive Treatment and Complication Prevention in Type 2 Diabetic Patients Identified by Screening (ADDITION-Europe).

“The 10-year follow-up findings support the use of intensive treatment of type 2 diabetes soon after diagnosis and have implications for policy relating to early detection and subsequent management of type 2 diabetes in primary care,” said Simon Griffin, MD.

Griffin, the study lead from the University of Cambridge, UK, presented the findings at the virtual European Association for the Study of Diabetes (EASD) Annual Meeting 2020.

Although the difference in the primary outcome between the intensive treatment and routine care groups favored the former, the difference was not statistically significant.

Still, “It looks like early intensive treatment of multiple risk factors soon after diagnosis is safe and seems to lower cardiovascular

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31